annual ROE:
-28.73%+0.38%(+1.31%)Summary
- As of today (August 1, 2025), ELVN annual return on equity is -28.73%, with the most recent change of +0.38% (+1.31%) on December 31, 2024.
- During the last 3 years, ELVN annual ROE has fallen by -86.42% (-149.80%).
- ELVN annual ROE is now -130.76% below its all-time high of 93.41%, reached on December 1, 2020.
Performance
ELVN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-31.84%-2.67%(-9.15%)Summary
- As of today (August 1, 2025), ELVN quarterly return on equity is -31.84%, with the most recent change of -2.67% (-9.15%) on March 31, 2025.
- Over the past year, ELVN quarterly ROE has dropped by -3.01% (-10.44%).
- ELVN quarterly ROE is now -148.40% below its all-time high of 65.78%, reached on September 30, 2022.
Performance
ELVN quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ELVN ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.3% | -10.4% |
| 3 y3 years | -149.8% | -180.0% |
| 5 y5 years | -130.8% | -262.7% |
ELVN ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -149.8% | +1.3% | -148.4% | +64.4% |
| 5 y | 5-year | -130.8% | +1.3% | -148.4% | +64.4% |
| alltime | all time | -130.8% | +1.3% | -148.4% | +64.4% |
ELVN ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | -31.84%(+9.2%) |
| Dec 2024 | -28.73%(-1.3%) | -29.17%(-1.0%) |
| Sep 2024 | - | -29.46%(+0.5%) |
| Jun 2024 | - | -29.31%(+1.7%) |
| Mar 2024 | - | -28.83%(+8.5%) |
| Dec 2023 | -29.11% | -26.56%(-18.8%) |
| Sep 2023 | - | -32.71%(-32.5%) |
| Jun 2023 | - | -48.46%(-45.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | -89.53%(-272.2%) |
| Dec 2022 | 49.02%(-15.0%) | 51.98%(-21.0%) |
| Sep 2022 | - | 65.78%(+8.7%) |
| Jun 2022 | - | 60.51%(+52.1%) |
| Mar 2022 | - | 39.78%(+103.3%) |
| Dec 2021 | 57.69%(-38.2%) | - |
| Dec 2021 | - | 19.57% |
| Dec 2020 | 93.41% | - |
FAQ
- What is Enliven Therapeutics, Inc. annual return on equity?
- What is the all time high annual ROE for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual ROE year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly return on equity?
- What is the all time high quarterly ROE for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly ROE year-on-year change?
What is Enliven Therapeutics, Inc. annual return on equity?
The current annual ROE of ELVN is -28.73%
What is the all time high annual ROE for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual return on equity is 93.41%
What is Enliven Therapeutics, Inc. annual ROE year-on-year change?
Over the past year, ELVN annual return on equity has changed by +0.38% (+1.31%)
What is Enliven Therapeutics, Inc. quarterly return on equity?
The current quarterly ROE of ELVN is -31.84%
What is the all time high quarterly ROE for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly return on equity is 65.78%
What is Enliven Therapeutics, Inc. quarterly ROE year-on-year change?
Over the past year, ELVN quarterly return on equity has changed by -3.01% (-10.44%)